The prescription-only 150 mg/mL medicine will be used alongside cognitive behavioural therapy and prescribed exclusively by ...

The timing could not be more significant. According to the National Mental Health Survey 2015–16, conducted by NIMHANS across ...

NEW HAVEN, Conn. (WTNH) — A groundbreaking clinical trial was recently presented at the Alzheimer’s Association International ...

In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a ...

Researchers say better education on cannabis compounds could reduce consumers turning to high-potency tetrahydrocannabinol, ...

Recent research published in the Journal of Psychopharmacology suggests that cannabidiol, a non-intoxicating compound found ...

Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders: Our Bureau, Bengaluru Tuesday, July 14, 2026, 16:25 Hrs [IST] Leiutis ...

Nearly 90% of trial participants improved with treatment ...

A new study has found cannabidiol (medicinal cannabis) to be a promising treatment for several drug-resistant forms of ...

For years, Alzheimer’s-related agitation had just one FDA-approved treatment, an antipsychotic. This spring, a ...

Patients with Alzheimer’s disease experienced rapid and significant improvements in agitation with a combination of CBD and ...